A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP

Clinical trial NCT02205112 · COMPLETED

Trial details

NCT number: NCT02205112
Sponsor: TaiGen Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Pneumonia

Start date: 2014-06-01
Primary completion: 2017-05-04
Enrollment: 598

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.